Immuron Limited - American Depositary Shares (IMRN) analyst actions
Rating and price-target actions on IMRN in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the IMRN overview →
3 measured IMRN analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Emerging Growth Research Releases Flash Report on Immuron; Maintains Buy-Extended Rating and Raises Price Target to $4.00 | Press release | — | -2.47% | |
| Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.90 Price Target | Press release | +10.39% | +1.30% | |
| Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target | Press release | +2.94% | -2.25% |
Keep exploring
More IMRN: earnings → · SEC filings → · IMRN overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ASPEN PHARMACRE HL UN/ADR (APNHY) | 204 | 0.00% | 15% |
| Benitec Biopharma Inc. (BNTC) | 203 | 0.00% | 48% |
| InfuSystems Holdings, Inc. (INFU) | 202 | 0.00% | 50% |
| Regulus Therapeutics Inc. (RGLS) | 201 | +0.26% | 55% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.